Gracell Biotechnologies Inc.

NASDAQ GRCL

Data sourced from iex and EODHD
Download Data

Gracell Biotechnologies Inc. Income Statement 2017 - 2023

This table shows the Income Statement for Gracell Biotechnologies Inc. going from 2017 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-06-30 2019-03-31 2018-12-31 2018-06-30 2018-03-31 2017-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - -
Cost of Revenue
M - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M - - - - - - - - 0 - - - - - - - - - - - - -
Operating Expenses
M - - - - - - - - 131 - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 32 37 36 36 36 29 32 32 43 30 25 25 8 7 6 8 7 7 7 3 3 3
Research and Development (R&D) Expenses
M 90 104 113 113 133 117 108 108 89 65 61 61 40 41 27 38 30 30 30 13 13 13
Other Operating Expenses
M - - - - - - - - 0 - - - - - - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -122 -141 -149 -149 -170 -146 -140 -140 -131 -96 -85 -85 -48 -48 -33 -46 -37 -37 -37 -16 -16 -16
Interest Expense
M 1 2 2 2 2 2 1 1 1 1 1 1 1 0 0 - - - - - - -
Non-operating Income/Expense
M 46 -9 19 19 -2 0 9 9 0 -1 2 2 -2 1 0 2 -2 -2 -2 0 0 0
EBT
M -68 -147 -131 -131 -172 -146 -129 -129 -129 -96 -84 -84 -51 -46 -32 -43 -35 -35 -35 -15 -15 -15
Income Tax Provision
M 0 0 0 0 0 -1 -12 -12 -2 0 -6 -6 0 -1 -1 -7 - - - - - -
Income after Tax
M -68 -147 -131 -131 -172 -145 -116 -116 -127 -96 -78 -78 -51 -45 -31 -36 - - - - - -
Non-Controlling Interest
M 0 -79 -84 0 0 0 0 0 0 0 2 16 - 17 11 11 - - - - - -
Net Income
M -68 -68 -68 -131 -172 -146 -159 -129 -129 -96 -100 -100 - -63 -43 -53 - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 83,924,681.00 68,270,352.00 67,691,595.00 67,691,595.00 67,682,951.00 67,671,148.00 65,773,320.00 65,773,320.00 67,298,922.00 67,233,401.00 60,897,684.00 60,897,684.00 65,563,199.00 19,808,955.00 19,808,955.00 19,808,955.00 36,966,545.00 36,966,545.00 36,966,545.00 36,966,545.00 36,966,545.00 36,966,545.00
EBITDA
M -109 -134 -130 -130 -164 -141 -128 -128 -127 -94 -82 -82 -48 -45 -32 -50 -35 -35 -35 -15 -15 -15
Depreciation and Amortization
M 12 7 19 19 6 5 12 12 4 2 9 9 0 3 1 1 1 1 1 1 1 1
EBIT
M -122 -141 -149 -149 -170 -146 -140 -140 -131 -96 -91 -91 -48 -48 -33 -51 -37 -37 -37 -16 -16 -16
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -0.02 -0.01 -0.02 -0.02 -0.16 0.80 9.58 9.58 1.47 0.33 6.74 6.74 -0.80 1.12 2.99 15.64 - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - - - - - -
Gross Profit Margin
% - - - - - - - - 100.00 - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - -35,822.95 - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - -35,323.77 - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - -34,807.10 - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - -35,822.95 - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - -35,323.77 - - - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email